FLGT News and Press, Fulgent Genetics Inc. From 02/26/21

Moderna (NASDAQ: MRNA) , Teladoc Health (NYSE: TDOC) and Fulgent Genetics (NASDAQ: FLGT) have all had incredible runs over the last year. Moderna is up 570%. Teladoc stock has jumped 127%. And Fulgent has run up 500%. What's the strongest stock? Healthcare and Cannab...

Fulgent Genetics (NASDAQ: FLGT) has been a six-bagger over the past 12 months. Why is the stock running so high?Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool contributor Taylor Carmichael discuss the bullish case for Fulgent Genetics. This segment was recorded live...

Because of COVID-19, investors in Moderna (NASDAQ: MRNA) , Teladoc Health (NYSE: TDOC) , and Fulgent Genetics (NASDAQ: FLGT) have had amazing returns over the last year. Is the virus going away soon? Will these stocks crash when it does? Healthcare and Cannabis Burea...

Fulgent Genetics (NASDAQ: FLGT) ranks among the best-performing stocks on the market so far this year. After skyrocketing in January, the stock has pulled back considerably over the last few weeks. In this Motley Fool Live video recorded on Feb. 17, 2021 , Fool.com cont...

TEMPLE CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it wi...

While vaccines are rolling out rapidly around the developed world, and uptake is expected to produce some version of herd immunity within the next six months, scientists are acclimating to the idea that we may be locked in a long-term battle with Covid-19 that could last years or even decades...

Are you looking for stocks that could make you rich? If so, there are a few names in the healthcare sector that deserve your attention. Investors can expect big gains ahead from shares of Clover Health (NASDAQ: CLOV) , Fulgent Genetics (NASDAQ: FLGT) , and Ocular Thera...

Fulgent Genetics (NASDAQ: FLGT) soared in 2020, with its stock gaining more than 300%. Investors hoping for a pullback in 2021 have been disappointed, as the stock has gained a jaw-dropping 200% so far this year. This has investors wondering whether there's a short squeeze at work, ...

Fulgent Genetics (NASDAQ: FLGT) was one of the undisputed winners last year, gaining a massive 300%. If you think that was impressive, consider this: the stock has already gained more than 200% in 2021, with no signs of slowing. So what's causing this huge run-up? On this clip f...

Fulgent Genetics is an upstart in the genetic testing business, and it has achieved remarkable business momentum since inception. Management is (very) well aligned and has an admirable track record. COVID-19 has been a tremendous business tailwind for Fulgent, as the COVID testing...